Drug intelligence / Profile preview

Celsior

Development stage
Unknown
Lead developer
Hospices Civils de Lyon
Modality
Small Molecules
Administration
Intracardiac, Perfusion
01

Overview

Celsior is a multi-component, cold crystalloid cardioplegia and organ preservation solution. It is specifically designed to provide myocardial protection during cardiac surgery and to preserve solid organs (heart, lung, liver, kidney, and pancreas) during transplantation. The solution's formulation includes mannitol and lactobionate to prevent cellular edema, histidine for acid-base buffering, reduced glutathione as an antioxidant to scavenge free radicals, and glutamate as a metabolic substrate to support energy production. Additionally, its high magnesium content acts as a natural calcium antagonist to prevent calcium overload during reperfusion. In the context of pediatric cardiac surgery, such as the arterial switch operation for transposition of the great vessels, Celsior is utilized to maintain myocardial viability during prolonged periods of induced cardiac arrest.

Brand names
Celsior
Other names
Celsior solution
02

Targets

GSH (Glutathione)Glu (Glutamate)

Beyond the preview

Go deeper on Celsior.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celsior.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call